Show simple item record

dc.contributor.authorPearson, Ryan M.
dc.contributor.authorHsu, Hao-jui
dc.contributor.authorBugno, Jason
dc.contributor.authorHong, Seungpyo
dc.date.accessioned2014-03-13T02:59:48Z
dc.date.available2014-03-13T02:59:48Z
dc.date.issued2014-03
dc.identifier.bibliographicCitationR. M. Pearson, H.-j. Hsu, J. Bugno, S. Hong, MRS Bulletin 39, (2014). DOI: 10.1557/mrs.2014.9en_US
dc.identifier.other10.1557/mrs.2014.9
dc.identifier.urihttp://hdl.handle.net/10027/11307
dc.descriptionThis is the author's copy of the post peer-reviewed manuscript. Some minor changes were made to this manuscript before it will be published by MRS Bulletin. For the final, formatted version, please see http://www.mrs.org/bulletin/ and look for the March 2014 issue. Copyright@MRS Bulletinen_US
dc.description.abstractThe ability of cancer-targeted nanoparticles (NPs) to reach their site of action and evoke a desired biological response after intravenous injection is critical to achieve clinically significant in vivo efficacy. Throughout their journey in the body, NPs must successfully traverse biological environments such as blood circulation and tumor microenvironments. The interactions that occur at the interface between NPs and biological components are complex, requiring a thorough understanding of the “nano-bio” interactions to design NPs with maximal therapeutic indices. In this article, we review the challenges presented by the multiscale, important biocompartments that NPs face, describe the crucial nano-bio interactions present at each stage, and discuss potential strategies to overcome those challenges. This review suggests design considerations for NPs to optimally modulate their physicochemical properties to achieve desired biological responses, which is expected to aid chemists, engineers, and clinical scientists to design and develop highly effective delivery platforms for cancer therapy.en_US
dc.description.sponsorshipThis work was supported by the Susan G. Komen Foundation under grant # KG100713, Alex’s Lemonade Stand Foundation for Childhood Cancer, and Korean Ministry of Small & Medium Business Administration. R.M.P. acknowledges support from UIC in the form of the Dean’s Scholarship.en_US
dc.publisherMaterials Research Societyen_US
dc.subjectNano-bioen_US
dc.subjectdrug deliveryen_US
dc.subjecttumor microenvironmenten_US
dc.subjectnanoparticlesen_US
dc.subjectendocytosisen_US
dc.subjectcell membraneen_US
dc.subjectnanocarrieren_US
dc.subjectBiomaterialen_US
dc.subjectpolymeren_US
dc.subjectbiomedicalen_US
dc.subjectnanoscaleen_US
dc.titleUnderstanding nano-bio interactions to improve nanocarriers for drug deliveryen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record